(Boursier.com) — Ikonisys SA, a company specializing in the early and accurate detection of cancer with a unique and fully automated solution for medical diagnostic laboratories, announces the installation of an Ikoniscope20 digital fluorescence microscope solution in one of the urology laboratories state-of-the-art in the United States, with more than 50 providers and delivering care using state-of-the-art technologies at multiple sites.
Manny Iglesias, Ikonisys USA Commercial Director, said, “The selection of the Ikoniscope20 by one of the most reputable urology laboratories, and part of one of the largest urology groups in the country , is further evidence of our solution’s technology leadership.This sale fits perfectly with the US go-to-market strategy announced at Ikonisys’ IPO, focusing on key key opinion leaders who could pave the way for further sales.”
©2022 Boursier.com